Find Copovidone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 25086-89-9, Poly(1-vinylpyrrolidone-co-vinyl acetate), Polectron 845, Luviskol va 28i, Luviskol va 37e, Luviskol va 64
Molecular Formula
C10H15NO3
Molecular Weight
197.23  g/mol
InChI Key
FYUWIEKAVLOHSE-UHFFFAOYSA-N

Copovidone
1 2D Structure

Copovidone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethenyl acetate;1-ethenylpyrrolidin-2-one
2.1.2 InChI
InChI=1S/C6H9NO.C4H6O2/c1-2-7-5-3-4-6(7)8;1-3-6-4(2)5/h2H,1,3-5H2;3H,1H2,2H3
2.1.3 InChI Key
FYUWIEKAVLOHSE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)OC=C.C=CN1CCCC1=O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Copovidone

2. Kollidon Va64

3. Poly(v-co-v-ac)

4. Poly(vinyl Pyrrolidone-co-vinyl Acetate)

5. Poly(vinylpyrrolidone-co-vinyl-acetate)

6. Polyvidone-vinylacetate 64

7. Pvp Va64

8. Pvp-va

9. Pvpva 64

2.2.2 Depositor-Supplied Synonyms

1. 25086-89-9

2. Poly(1-vinylpyrrolidone-co-vinyl Acetate)

3. Polectron 845

4. Luviskol Va 28i

5. Luviskol Va 37e

6. Luviskol Va 64

7. Kolima 10

8. Kolima 35

9. Ethenyl Acetate;1-ethenylpyrrolidin-2-one

10. Gantron S 860

11. Pvp-va

12. Ganex E 535

13. Vinyl Acetate-vinylpyrrolidone Copolymer

14. Vinylpyrrolidinone-vinyl Acetate Copolymer

15. Gaf-s 630

16. Vinyl Acetate-vinylpyrrolidone Polymer

17. Vinylpyrrolidone-vinyl Acetate Polymer

18. Luviskol Va 281

19. Vinyl Acetate-vinylpyrrolidinone Polymer

20. Vinylpyrrolidinone-vinyl Acetate Polymer

21. Vinylpyrrolidone-vinyl Acetate Copolymer

22. Luviskol Va 28 I

23. Luviskol Va 37 E

24. N-vinylpyrrolidone-vinyl Acetate Polymer

25. Vinyl Acetate-n-vinylpyrrolidone Polymer

26. Vinyl Acetate-vinylpyrrolidinone Copolymer

27. Vinyl Acetate-n-vinylpyrrolidinone Polymer

28. Vinyl Acetate-n-vinylpyrrolidone Copolymer

29. Acetic Acid Vinyl Ester, Polymer With 1-vinyl-2-pyrrolidinone

30. Acetic Acid Ethenyl Ester, Polymer With 1-ethenyl-2-pyrrolidinone

31. Vinyl Acetate-n-vinylpyrrolidinone Copolymer

32. I 535

33. I 635

34. I 735

35. S 630

36. 1-vinyl-2-pyrrolidone-vinyl Acetate Copolymer

37. Vinyl Acetate-1-vinyl-2-pyrrolidinone Polymer

38. Vinyl Acetate-n-vinyl-2-pyrrolidone Copolymer

39. Vinyl Acetate-n-vinyl-2-pyrrolidinone Copolymer

40. Ethenyl Acetate, Polymer With 1-ethenyl-2-pyrrolidinone

41. Mfcd00134018

42. Acetic Acid Ethenyl Ester, Polymer With 1-ethenyl-2-pyrrolidinoneother Ca Index Names:2-pyrrolidinone, 1-ethenyl-, Polymer With Ethenyl Acetate

43. 2-pyrrolidinone, Polymer With Ethenyl Acetate

44. Luviskol Va-64

45. Vinyl Acetate N-vinyl-pyrrolidone Polymer

46. Schembl29127

47. Copovidone (technical Grade)

48. Vinylpyrrolidone/vinyl Acetate

49. Vinyl Pyrrolidone/vinyl Acetate

50. N-vinylpyrrolidone/vinyl Acetate

51. 1-vinylpyrrolidone Vinyl Acetate

52. Bcp31918

53. Nsc114023

54. Nsc114024

55. Nsc114025

56. Nsc114026

57. Akos015898247

58. Nsc-114023

59. Nsc-114024

60. Nsc-114025

61. Nsc-114026

62. Poly(1-vinylpyrrolidone-co-vinylacetate)

63. Vinyl Acetate-vinyl Pyrrolidone Copolymer

64. 1-ethenylpyrrolidin-2-one; Ethenyl Acetate

65. Ethenyl Ethanoate; 1-ethenylpyrrolidin-2-one

66. Ft-0659810

67. A817635

68. Acetic Acid Ethenyl Ester; 1-ethenyl-2-pyrrolidinone

69. Poly(1-vinylpyrrolidone-co-vinyl Acetate);polectron 845;luviskol Va 28i

70. Poly(1-vinylpyrrolidone - Vinyl Acetate) (copolymer, 7:3) (50% In Ethanol)

71. Poly(1-vinylpyrrolidone-co-vinyl Acetate) (copolymer, 3:7) (50% In Ethanol)

72. 733045-73-3

2.3 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 197.23 g/mol
Molecular Formula C10H15NO3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass197.10519334 g/mol
Monoisotopic Mass197.10519334 g/mol
Topological Polar Surface Area46.6 Ų
Heavy Atom Count14
Formal Charge0
Complexity186
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

Huangshan Bonsun Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CST
Not Confirmed
arrow

Huangshan Bonsun Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CST
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

Shanghai Yuking Water Soluble Mate...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CST
Not Confirmed
arrow

Shanghai Yuking Water Soluble Mate...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CST
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

BASF

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CST
Not Confirmed
arrow

BASF

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CST
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Star-Tech Specialty Products Co Lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CST
Not Confirmed
arrow

Star-Tech Specialty Products Co Lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CST
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"COPOVIDONE","year":"2021","qtr":"Q1","strtotime":1614105000,"product":"LEDIPASVIR COPOVIDONE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"SANA'A","customer":"DLS PHARMAG DMCC","customerCountry":"YEMEN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2916.3","totalValueFC":"2883.9","currency":"USD","unitRateINR":209970,"date":"24-Feb-2021","totalValueINR":"209970","totalValueInUsd":"2883.9","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29339990","bill_no":"4000556","productDescription":"API","marketType":"","country":"YEMEN, DEMOCRATI","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622745000,"product":"VELPATASVIR COPOVIDONE IHS","address":"4-7-101 SCIENTIST COLONY,HABSIGUDA","city":"HYDERABAD, TELANGANA","supplier":"OPTRIX LABORATORIES PRIVATE ","supplierCountry":"INDIA","foreign_port":"LAHORE","customer":"M\/S. ORDER OF MEEZAN BANK LIMITED,","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"1900.6","totalValueFC":"46548.1","currency":"USD","unitRateINR":136936.39999999999,"date":"04-Jun-2021","totalValueINR":"3423410","totalValueInUsd":"46548.1","indian_port":"HYDERABAD AIR","hs_no":"29141990","bill_no":"2210029","productDescription":"API","marketType":"","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"4-7-101 SCIENTIST COLONY,HABSIGUDA, HYDERABAD, TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719426600,"product":"TUCATINIB COPOVIDONE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS (JORDAN)","customerCountry":"JORDAN","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"25000","totalValueFC":"49166.3","currency":"USD","unitRateINR":2052189.155,"date":"27-Jun-2024","totalValueINR":"4104378.31","totalValueInUsd":"49166.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"1993193","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742409000,"product":"VELPATASVIR COPOVIDONE","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA","customerCountry":"EGYPT","quantity":"50.62","actualQuantity":"50.62","unit":"KGS","unitRateFc":"3500","totalValueFC":"175952.3","currency":"USD","unitRateINR":301077.95337811142,"date":"20-Mar-2025","totalValueINR":"15240566","totalValueInUsd":"175952.3","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9179837","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"PHARMACEUTICALS RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG - VELPATASVIR COPOVIDONE, CAS NO: 1844064-96-5","address":"SHED NO F-1, IDA, ROAD NO.6","city":"KUKATPALLY","supplier":"HANGZHOU QICHUANG CHEMICAL","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"MS VIRUJ CHEMATRIX PRIVATE LIMITED","customerCountry":"INDIA","quantity":"18.00","actualQuantity":"18","unit":"KGS","unitRateFc":"2700","totalValueFC":"49180.6","currency":"USD","unitRateINR":"227745","date":"16-May-2024","totalValueINR":"4099410","totalValueInUsd":"49180.6","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29349990","bill_no":"1001214","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"ROOM 1204, NO. 46 TIANMUSHAN ROAD, XIHU DISTRICT, HANGZHOU CHINA CN","customerAddress":"SHED NO F-1, IDA, ROAD NO.6"}]
24-Feb-2021
20-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   

Impressions: 2540

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

#PharmaFlow by PHARMACOMPASS
12 Sep 2024

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Others

read-more
read-more

01

XYZ Pharma

Gabon
arrow
Excipient World
Not Confirmed

XYZ Pharma

Gabon
arrow
Excipient World
Not Confirmed

Copovidone (100 mg)

CAS Number : 2586-89-9

Quantity Per Vial : 100

Sale Unit : mg

Price : $275.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1148500 / F0C194

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 25086-89-9 / Copovidone API manufacturers, exporters & distributors?

Copovidone manufacturers, exporters & distributors 1

30

PharmaCompass offers a list of Copovidone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Copovidone manufacturer or Copovidone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Copovidone manufacturer or Copovidone supplier.

PharmaCompass also assists you with knowing the Copovidone API Price utilized in the formulation of products. Copovidone API Price is not always fixed or binding as the Copovidone Price is obtained through a variety of data sources. The Copovidone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Copovidone

Synonyms

25086-89-9, Poly(1-vinylpyrrolidone-co-vinyl acetate), Polectron 845, Luviskol va 28i, Luviskol va 37e, Luviskol va 64

Cas Number

25086-89-9

Copovidone Manufacturers

A Copovidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copovidone, including repackagers and relabelers. The FDA regulates Copovidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copovidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Copovidone Suppliers

A Copovidone supplier is an individual or a company that provides Copovidone active pharmaceutical ingredient (API) or Copovidone finished formulations upon request. The Copovidone suppliers may include Copovidone API manufacturers, exporters, distributors and traders.

click here to find a list of Copovidone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Copovidone USDMF

A Copovidone DMF (Drug Master File) is a document detailing the whole manufacturing process of Copovidone active pharmaceutical ingredient (API) in detail. Different forms of Copovidone DMFs exist exist since differing nations have different regulations, such as Copovidone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Copovidone DMF submitted to regulatory agencies in the US is known as a USDMF. Copovidone USDMF includes data on Copovidone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Copovidone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Copovidone suppliers with USDMF on PharmaCompass.

Copovidone CEP

A Copovidone CEP of the European Pharmacopoeia monograph is often referred to as a Copovidone Certificate of Suitability (COS). The purpose of a Copovidone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Copovidone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Copovidone to their clients by showing that a Copovidone CEP has been issued for it. The manufacturer submits a Copovidone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Copovidone CEP holder for the record. Additionally, the data presented in the Copovidone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Copovidone DMF.

A Copovidone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Copovidone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Copovidone suppliers with CEP (COS) on PharmaCompass.

Copovidone GMP

Copovidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Copovidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copovidone GMP manufacturer or Copovidone GMP API supplier for your needs.

Copovidone CoA

A Copovidone CoA (Certificate of Analysis) is a formal document that attests to Copovidone's compliance with Copovidone specifications and serves as a tool for batch-level quality control.

Copovidone CoA mostly includes findings from lab analyses of a specific batch. For each Copovidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Copovidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Copovidone EP), Copovidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copovidone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty